Something to Hide? Big Pharma Attorneys Say “No” to False Claims Act

The pharmaceutical industry is attempting to curtail the success of the federal False Claims Act by discouraging its application and expansion to additional states. While big pharma lawyers argue that these cases are nothing more than a “lottery ticket,” Jill Kozeny, Senator Grassley’s spokeswoman, attributes the recovery of “billions of dollars that would have been otherwise lost to fraud” to federal False Claims Act as further discussed in a recent article that appeared in The Washington Drug Letter. (Stephen Langel, Industry Attorneys Warn States Not to Enact False Claims Acts, Washington Drug Letter (May 8, 2006).